Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30 (Q44843117)

From Wikidata
Jump to navigation Jump to search
scientific article published in May 2004
edit
Language Label Description Also known as
English
Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30
scientific article published in May 2004

    Statements

    Effect of prophylactic treatment with intravesical epirubicin on recurrence of superficial bladder cancer--The 6th Trial of the Japanese Urological Cancer Research Group (JUCRG): a randomized trial of intravesical epirubicin at dose of 20mg/40ml, 30 (English)
    Masao Kuroda
    Tadao Niijima
    Toshihiko Kotake
    Hideyuki Akaza
    Shiro Hinotsu
    6th Trial of the Japanese Urological Cancer Research Group
    600-605

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit